Valeritas (VLRX) Trading 10.7% Higher
Valeritas Holdings Inc (NASDAQ:VLRX)’s share price traded up 10.7% during trading on Wednesday . The stock traded as high as $1.03 and last traded at $1.14. 7,214 shares changed hands during trading, a decline of 97% from the average session volume of 224,836 shares. The stock had previously closed at $1.03.
Several equities analysts have recently commented on the stock. Oppenheimer assumed coverage on shares of Valeritas in a research report on Thursday, July 5th. They set an “outperform” rating and a $3.50 price target on the stock. assumed coverage on shares of Valeritas in a research report on Thursday, July 5th. They set an “outperform” rating and a $3.50 price target on the stock. Citigroup assumed coverage on shares of Valeritas in a research report on Thursday, July 5th. They set an “outperform” rating and a $3.50 price target on the stock. Finally, ValuEngine raised shares of Valeritas from a “hold” rating to a “buy” rating in a research report on Saturday, June 2nd. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $3.67.
The company has a current ratio of 4.03, a quick ratio of 3.42 and a debt-to-equity ratio of 13.66. The stock has a market capitalization of $22.74 million, a P/E ratio of -0.12 and a beta of 4.14.
A number of hedge funds and other institutional investors have recently modified their holdings of the business. Essex Investment Management Co. LLC bought a new position in Valeritas in the second quarter worth about $448,000. C WorldWide Group Holding A S lifted its holdings in Valeritas by 28.0% in the second quarter. C WorldWide Group Holding A S now owns 316,194 shares of the company’s stock worth $424,000 after acquiring an additional 69,216 shares during the last quarter. Finally, Bainco International Investors bought a new position in Valeritas in the second quarter worth about $228,000. 7.38% of the stock is currently owned by hedge funds and other institutional investors.
Valeritas Company Profile (NASDAQ:VLRX)
Valeritas Holdings, Inc, a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States and China. It offers V-Go, a wearable insulin delivery device for basal-bolus therapy. The company also develops h-Patch, a controlled delivery technology platform; Mini-Ject technology for needle-free injection systems; and Micro-Trans technology for microneedle design, fabrication, and drug delivery.
Read More: Hedge Funds – Risk or Reward?
Receive News & Ratings for Valeritas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeritas and related companies with MarketBeat.com's FREE daily email newsletter.